Position in ABBV
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$1,187,992
-$621,742 QoQ
Shares Held
4,721
-43.3% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.17%
of 13F equity value
Holder Rank
#2,388
of 4,153 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Wellington Shields Capital Management, LLC holds $19,991,464 across 9 Drug Manufacturers - General names. ABBV ranks #5 (5.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
9,793 | $11,746,018 | |
| 2 | JNJ |
Johnson & Johnson
|
12,573 | $3,193,164 | |
| 3 | MRK |
Merck & Co., Inc.
|
10,175 | $1,307,487 | |
| 4 | AMGN |
Amgen Inc
|
3,578 | $1,295,665 | |
| 5 | ABBV |
AbbVie Inc.
This page
|
4,721 | $1,187,992 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
12,407 | $714,891 | |
| 7 | PFE |
Pfizer Inc
|
13,191 | $317,639 | |
| 8 | GSK |
GSK plc
|
3,103 | $162,659 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,187,992 | 4,721 | Shares | Sole | 2026-08-10 | |
| 2026-03-31 | $1,809,734 | 8,321 | Shares | Sole | 2026-05-04 | |
| 2025-12-31 | $3,511,434 | 15,368 | Shares | Sole | 2026-02-09 | |
| 2025-09-30 | $3,558,306 | 15,368 | Shares | Sole | 2025-11-05 | |
| 2025-06-30 | $2,856,320 | 15,388 | Shares | Sole | 2025-08-05 | |
| 2025-03-31 | $3,245,045 | 15,488 | Shares | Sole | 2025-05-08 | |
| 2024-12-31 | $3,733,121 | 21,008 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $4,153,399 | 21,032 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $3,607,408 | 21,032 | Shares | Sole | 2024-08-05 | |
| 2024-03-31 | $3,706,099 | 20,352 | Shares | Sole | 2024-05-03 | |
| 2023-12-31 | $3,262,428 | 21,052 | Shares | Sole | 2024-02-09 | |
| 2023-09-30 | $3,080,921 | 20,669 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $2,796,321 | 20,755 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $3,619,611 | 22,712 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $3,589,519 | 22,211 | Shares | Sole | 2023-02-15 | |
| 2022-09-30 | $2,980,804 | 22,210 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $3,792,088 | 24,759 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $11,810,524 | 72,855 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $4,466,981 | 32,991 | Shares | Sole | 2022-02-15 | |
| 2021-09-30 | $2,965,346 | 27,490 | Shares | Sole | 2021-11-10 | |
| 2021-06-30 | $3,755,755 | 33,343 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $10,542,792 | 97,420 | Shares | Sole | 2021-05-12 | |
| 2020-12-31 | $3,620,277 | 33,787 | Shares | Sole | 2021-02-09 | |
| 2020-09-30 | $2,404,433 | 27,451 | Shares | Sole | 2020-11-10 | |
| 2020-06-30 | $2,714,578 | 27,649 | Shares | Sole | 2020-08-05 | |
| 2020-03-31 | $1,874,807 | 24,607 | Shares | Sole | 2020-05-07 | |
| No filing history on record for this holder in this stock. | ||||||